A potent marker that allows the discrimination of inflammatory CD1c-CD11c+ DCs from resident CD1c+CD11c+ DCs in patients with psoriasis is TNF-related apoptosis-inducing ligand (TRAIL)31. This evidence concerns the gene ITGAX and psoriasis.